CBS Removes Trans Mandates From Its Reporting; NY Times Accuses War Crimes With...
Anti-ICE Protesters Try to Shame an Agent — It Backfires Spectacularly
For the Trans Activist Class, It’s All About Them
Ilhan Omar Claims ICE Isn’t Arresting Criminals. Here's Proof That She's Lying.
Check Out President Trump's 'Appropriate and Unambiguous' Response to Heckler
'The Constitution of a Deity' RFK Jr. on President Trump's Diet
Father-in-Law of Renee Good Refuses to Blame ICE, Urges Americans to Turn to...
Iranian State Media Airs a Direct Assassination Threat Against President Trump
US Halts Immigrant Visas From 75 Countries Over Welfare Abuse Concerns
Living Through Iran’s Slaughter: One Iranian Woman Describes the Horror and Hope Under...
Tricia McLaughlin Defends ICE's Visible Presence
House Committee IT Staffer Charged With Stealing 240 Government Phones Worth $150K
Justice Department Challenges Minnesota’s Affirmative Action Hiring Requirements
Founder of LGBTQ+ Nonprofit Casa Ruby Sentenced in Federal Fraud Case
DC Rapper 'Taliban Glizzy' Sentenced to Over 18 Years for Multi-State Jewelry Heists
Tipsheet

Rapid Response Test Was Just Approved for the Wuhan Coronavirus

AP Photo/Ted S. Warren

The United States Food and Drug Administration (FDA) on Friday announced that the agency approved the first of its kind rapid response test to detect the Wuhan coronavirus. The agency used an emergency use authorization to fast-track the test's approval. According to the FDA, the test's results are produced roughly 45 minutes after the test is administered. 

Advertisement

The company producing the tests, Cepheid, said the test was designed so that the tests could be used in the 5,000 GeneXpert testing systems throughout the country. This means hospitals could receive results at the point-of-care. These systems are automated, do not require specific training and are capable of running 24/7, something hospitals across the nation already do.

"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities," Dr. David Persing, MD, Ph.D., Chief Medical and Technology Officer at Cepheid said in a statement. "An accurate test delivered close to the patient can be transformative — and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources."

Cepid said the tests will begin shipping next week.

Although these test will be readily available, Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Diseases, said asymptomatic people should not be tested for the Wuhan coronavirus. Doing so puts health care workers at greater risk because of the lack of personal protective equipment [PPE].

Advertisement

Related:

CORONAVIRUS FDA

"Let me tell you about one of the unintended consequences of individuals who don't need to get tested flood the desire to get tested. Currently, and I hope we will be able to change it, and make it much less reliable, PPEs," he explained during Saturday's press conference. "When you go in and get tested, you are consuming personal protective equipment: masks and gowns. Those are high priority for the health care workers who are taking care of people who have coronavirus disease."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos